2,602
Views
1
CrossRef citations to date
0
Altmetric
Clinical Trial Protocol

Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors

ORCID Icon, , , , , , , , , & show all
Pages 1069-1077 | Received 10 Nov 2023, Accepted 14 Dec 2023, Published online: 12 Jan 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.